• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

846
68
51
50
30

COUNTRY

30
13
13
12
12

PRICE

681
866
964
1,564

PUBLISHED

16
58
323
1,564

PRODUCT TYPE

959
499
86
16
2
2

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE
Sexually-Transmitted Diseases in the US 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in the US 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in the US 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,...

January 2014
FROM
World Enteric Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers World Enteric Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers - Product Thumbnail Image

World Enteric Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers

This new 389-page report from the author contains 97 tables and provides analysis of the global enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts...

January 2014
FROM
Consensus Outlook: Multiple Sclerosis Consensus Outlook: Multiple Sclerosis - Product Thumbnail Image

Consensus Outlook: Multiple Sclerosis

Over the next five years, the global multiple sclerosis (MS) market is set to grow from $14 3 billion in 2012 to $21 5 billion in 2017 Primary drivers of this growth will be the entry of new pipeline...

December 2013
FROM

Shigella Infections (Shigellosis) - Pipeline Review, H2 2013

Shigella Infections (Shigellosis) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Shigella Infections (Shigellosis) - Pipeline Review, H2 2013', provides an overview of the indication’s...

December 2013
FROM

Klebsiella Infections - Pipeline Review, H2 2013

Klebsiella Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Klebsiella Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

December 2013
FROM

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Clostridium Difficile Infections (Clostridium Difficile Associated...

December 2013
FROM

Enterococcus Faecium Infections - Pipeline Review, H2 2013

Enterococcus Faecium Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Enterococcus Faecium Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

December 2013
FROM

Trypanosomiasis - Pipeline Review, H2 2013

Trypanosomiasis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Trypanosomiasis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

December 2013
FROM

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013', provides an overview of the indication’s...

December 2013
FROM

Anthrax - Pipeline Review, H2 2013

Anthrax - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Anthrax - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2013
FROM

Staphylococcus Aureus Infections - Pipeline Review, H2 2013

Staphylococcus Aureus Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Staphylococcus Aureus Infections - Pipeline Review, H2 2013', provides an overview of the indication’s...

December 2013
FROM

Bacteremia - Pipeline Review, H2 2013

Bacteremia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bacteremia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

December 2013
FROM

Tularaemia - Pipeline Review, H2 2013

Tularaemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Tularaemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

December 2013
FROM

Neisseria Meningitidis Infections - Pipeline Review, H2 2013

Neisseria Meningitidis Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Neisseria Meningitidis Infections - Pipeline Review, H2 2013', provides an overview of the indication’s...

December 2013
FROM

Rubella - Pipeline Review, H2 2013

Rubella - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Rubella - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2013
FROM

Ebola and Marburg Infections - Pipeline Review, H2 2013

Ebola and Marburg Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Ebola and Marburg Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

December 2013
FROM

Plague - Pipeline Review, H2 2013

Plague - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Plague - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2013
FROM

Warts - Pipeline Review, H2 2013

Warts - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Warts - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2013
FROM

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2013

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline...

December 2013
FROM

Burkholderia Infections - Pipeline Review, H2 2013

Burkholderia Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Burkholderia Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

December 2013
FROM
Loading Indicator

Our Clients

Our clients' logos